Magnetocardiographically-guided catheter ablation.
After more than 30 years since the first magnetocardiographic (MCG) recording was carried out with induction coils, MCG is now approaching the threshold of clinical use. During the last 5 years, in fact, there has been a growing interest of clinicians in this new method which provides an unrivalled accuracy for noninvasive, three-dimensional localization of intracardiac source. An increasing number of laboratories are reporting data validating the use of MCG as an effective method for preoperative localization of arrhythmogenic substrates and for planning the best catheter ablation approach for different arrhythmogenic substrates. In this article, available data from literature have been reviewed. We consider the clinical use of MCG to localize arrhythmogenic substrates in patients with Wolff-Parkinson-White syndrome and in patients with ventricular tachycardia in order to assess the state-of-the-art of the method on a large number of patients. This article also addresses some suggestions for industrial development of more compact, medically oriented MCG equipments at reasonable cost.
Fenici
R R
RR
Centro di Biomagnetismo-Fisiologia Clinica, Università Cattolica del Sacro Cuore, Rome, Italy.
Covino
M
M
Cellerino
C
C
Di Lillo
M
M
De Filippo
M C
MC
Melillo
G
G
D017115:Catheter Ablation / Q000379:methods*; D004562:Electrocardiography / Q000379:methods*; D006801:Humans; D008280:Magnetics; D017180:Tachycardia, Ventricular / Q000503:physiopathology / Q000601:surgery*; D014927:Wolff-Parkinson-White Syndrome / Q000503:physiopathology / Q000601:surgery*